Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course

OBJECTIVES: Triggering receptor expressed on myeloid cells-1 (TREM-1) is an amplifier of inflammatory signals. Recently, a soluble form of TREM-1 (sTREM-1) was described. This study aimed to investigate the role of serum sTREM-1 in patients with adult-onset Still’s disease (AOSD). METHODS: Serum sTR...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Rheumatology (Oxford)
Auteurs principaux: Wang, Zhihong, Chi, Huihui, Sun, Yue, Teng, Jialin, Feng, Tienan, Liu, Honglei, Cheng, Xiaobing, Ye, Junna, Shi, Hui, Hu, Qiongyi, Jia, Jinchao, Liu, Tingting, Wan, Liyan, Zhou, Zhuochao, Qiao, Xin, Yang, Chengde, Su, Yutong
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590420/
https://ncbi.nlm.nih.gov/pubmed/32276274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa135
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires